2 Jun 2023 15:53
2 June 2023
Medica Group Plc
Notice of AGM
Medica Group Plc (LSE:MGP, the "Company"), an international provider of high-quality telemedicine services, announces that, further to the publication on 28 April 2023 of the Company's Annual Report and Accounts for the year ended 31 December 2022, the Company has today posted or made available to shareholders the 2023 Notice of Annual General Meeting (the "Notice of AGM") and related form of proxy.
Electronic copies of these documents are available on the Company's website at
www.medicagroupplc.com/investors/agm/
A copy of the Notice of AGM will be submitted to the National Storage Mechanism and be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
The AGM will be held on 30 June 2023 at 10.30am at the offices of DLA Piper at 160 Aldersgate Street, London, EC1A 4HT.
For further information, please contact:
Medica Group Plc: Stuart Quin, Chief Executive Officer Richard Jones, Chief Financial Officer
| +44 (0)33 33 111 222
|
FTI Consulting (Public Relations Adviser to Medica) Ben AtwellVictoria Foster MitchellSam Purewal medicagroupplc@fticonsulting.com
| +44 (0)20 3727 1000 |
Liberum (Joint Broker) Phil Walker Richard Lindley
| +44 (0)20 3100 2000 |
Numis (Joint Broker) Freddie Barnfield Duncan Monteith Euan Brown
| +44 (0)20 7260 1000
|
About Medica Group PLC
Medica (LSE:MGP) is an international provider of high-quality telemedicine services. It is the market leader in teleradiology in the UK and Ireland, working with more than 100 NHS Trusts and HSE hospitals in Ireland, in addition to private hospitals, insurance groups and diagnostic imaging companies. Its network of consultant radiologists, radiographers and specialist doctors interpret and report MRI, CT, ultrasound and X-ray images on behalf of healthcare providers, using Medica's bespoke, secure technology platform for fast and responsive delivery. The company's core services include NightHawk, an urgent, out-of-hours offering available to clients 24/7 with dedicated pathways for stroke and major trauma, and Elective, for routine reporting.
In Ireland, Medica carries out patient scanning, as well as reporting. Through its US business, RadMD, Medica provides global pharmaceutical and biotech companies, as well as contract research organisations with specialist imaging services for clinical trials.
For more information please visit: www.medicagroupplc.com